Blackrock Inc vs GeneDx Holdings Corp — how do they compare? Blackrock Inc trades at $1,148.43 (market cap $177.92B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: Blackrock Inc is far larger — about 72.9× GeneDx Holdings Corp's market cap, and Blackrock Inc pays a 2% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| BLK | WGS | |
|---|---|---|
Market Cap | $177.92B | $2.44B |
Volume | 641,547 | — |
Sector | Financials | Technology |
52-Week High | $1.20K | $167.51 |
52-Week Low | $922.90 | $34.51 |
Enterprise Value | $179.02B | $2.48B |
Dividend Yield | 2% | — |
Signals from Pluang's Aura AI — not financial advice
BLK trades at $1,131.40, down slightly by 0.44% today, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $24.22 billion for 2025, with net income of $5.55 billion, and has consistently beaten EPS estimates in recent quarters. Recent news highlights BlackRock's involvement in a major AI financing initiative with Nvidia and other firms.
The outlook remains positive given strong earnings performance and a consensus buy rating from analysts, with a price target of $1,350. Key risks include potential legal challenges from investor lawsuits and volatile cash flow trends, but institutional confidence and strategic partnerships provide a solid foundation for growth.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →